Galderma — full event log
Every event we have on file across every reporting year. The Data-by-year tab summarises the top 10 per year; this page shows them all.
← back to Data by year2024· 13 events
In 2024, Galderma launched a top supplier engagement program covering the top 80-90 suppliers in the most carbon-intensive procurement categories. Phase 1 focused on primary data collection including detailed life cycle assessments for specific raw materials to improve Scope 3 calculation accuracy. Phase 2 included discussions to identify mutually beneficial GHG reduction initiatives.
sustainability_report p.75
Galderma's Clean Beauty Charter lists ingredients to avoid/not use as part of every new Dermatological Skincare product development cycle. In 2024, the charter started including environmental assessment of ingredients (biodegradability, carbon footprint) to inform Scope 3 reduction efforts.
sustainability_report p.71
In 2024, 50% of Galderma affiliates received Great Place to Work recognitions, including Galderma U.S. with workforce of ~1,200 people.
sustainability_report p.35
Galderma set target to achieve Scope 1 & 2 carbon neutrality across its four manufacturing plants by 2030. Includes phasing capex to replace carbon-intensive equipment and maintaining 100% renewable electricity.
sustainability_report p.31
Galderma debuted as a publicly-listed company (GALD) on the SIX Swiss Exchange on March 22, 2024 — the largest IPO in Switzerland since 2017 and one of the largest healthcare IPOs ever.
sustainability_report p.8
Reduce water withdrawal intensity by 20% from a 2022 baseline and reduce waste intensity by 20% from a 2022 baseline across manufacturing plants by 2030.
sustainability_report p.67
All four Galderma manufacturing plants obtained and maintain ISO 45001, ISO 14001 and OHSAS 18001 certifications.
sustainability_report p.31
L'Oréal acquired a 10% stake in Galderma post-IPO and joined in a complementary R&D collaboration.
sustainability_report p.10
Galderma achieved 100% renewable electricity across all four manufacturing sites in 2023 (up from 57% in 2022) and maintained this in 2024. The company commits to maintaining 100% renewable electricity in its manufacturing plants as part of its Scope 1 & 2 carbon neutrality ambition by 2030.
sustainability_report p.31
To achieve Scope 1 & 2 carbon neutrality in manufacturing plants by 2030, Galderma's plan includes the acquisition of high-quality carbon credits to compensate for residual emissions, alongside replacing carbon-intensive equipment (e.g., gas boilers) and maintaining 100% renewable electricity. The company does not distinguish removals from offsets explicitly.
sustainability_report p.67
Galderma reduced water withdrawal intensity by more than 10% year-over-year in 2024 (5.0 m3/ton bulk vs 5.6 in 2023) and reduced waste intensity by more than 10% YoY. All manufacturing plants send zero waste to landfill. Target: 20% reduction in both water and waste intensity by 2030 vs 2022 baseline.
sustainability_report p.31
In 2024, Galderma launched a broad-based Sustainable Packaging Initiative to identify all potential sustainable packaging solutions across the Dermatological Skincare portfolio. It prioritizes initiatives by impact and feasibility and considers resource availability such as post-consumer recycled (PCR) plastic. A multi-disciplinary team includes Operations, Procurement, R&D, Commercial and ESG.
sustainability_report p.71
Galderma is phasing specific capital expenditure to replace carbon-intensive equipment such as gas boilers across its four manufacturing plants in Alby-sur-Chéran, Baie-D'Urfé, Hortolândia and Uppsala. Individual decarbonization plans are tailored to each site's specificity and maturity.
sustainability_report p.31
2023· 2 events
Galderma achieved 100% renewable electricity across all four manufacturing sites in 2023, up from 57% in 2022.
sustainability_report p.67
Scope 3 emissions were first assessed in 2023 (332.1 ktCO2e). No assessment was performed for 2022.
sustainability_report p.67